Umpqua Bank Sells 55 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Umpqua Bank reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,887 shares of the medical equipment provider’s stock after selling 55 shares during the quarter. Umpqua Bank’s holdings in Intuitive Surgical were worth $1,556,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Hillsdale Investment Management Inc. boosted its stake in Intuitive Surgical by 40.1% during the fourth quarter. Hillsdale Investment Management Inc. now owns 699 shares of the medical equipment provider’s stock valued at $365,000 after buying an additional 200 shares during the last quarter. Plancorp LLC purchased a new position in Intuitive Surgical during the 4th quarter worth $224,000. Mizuho Securities USA LLC increased its holdings in shares of Intuitive Surgical by 46.8% in the 4th quarter. Mizuho Securities USA LLC now owns 33,758 shares of the medical equipment provider’s stock valued at $17,620,000 after acquiring an additional 10,757 shares during the period. ZEGA Investments LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth $1,163,000. Finally, TD Private Client Wealth LLC lifted its position in Intuitive Surgical by 8.1% during the 4th quarter. TD Private Client Wealth LLC now owns 3,988 shares of the medical equipment provider’s stock worth $2,082,000 after acquiring an additional 299 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 0.1 %

Shares of NASDAQ ISRG opened at $492.49 on Friday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a 50-day moving average of $562.24 and a two-hundred day moving average of $531.34. The company has a market cap of $175.41 billion, a PE ratio of 76.83, a P/E/G ratio of 5.85 and a beta of 1.43.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ISRG. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. CICC Research started coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective for the company. Robert W. Baird cut their price objective on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research note on Tuesday. Raymond James boosted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Finally, Evercore ISI upped their price objective on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Insider Transactions at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock worth $17,691,621 in the last quarter. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.